FGFR4 and neoplasm: Cellular functional and mechanistic studies indicated that FGF17 knockdown inhibited the FGFR4/MEK5/ERK5/NRF2 signaling axis, disrupted redox balance, and suppressed EMT progression, thereby reducing tumor cell migration and invasion.